The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Abbott Laboratories | Com | 002824100 | 200,878 | 1,825 | SH | SOLE | 0 | 1,825 | 0 | 0 | ||
| Microsoft Corporation | Com | 594918104 | 389,201 | 1,035 | SH | SOLE | 0 | 1,035 | 0 | 0 | ||
| NextEra Energy Inc | Com | 65339F101 | 283,960 | 4,675 | SH | SOLE | 0 | 4,675 | 0 | 0 | ||
| Procter & Gamble Co | Com | 742718109 | 233,292 | 1,592 | SH | SOLE | 0 | 1,592 | 0 | 0 | ||